About Oculis Holding AG 
Oculis Holding AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 8 Schemes (5.72%)
Foreign Institutions
Held by 26 Foreign Institutions (17.86%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-37 Million
Pharmaceuticals & Biotechnology
USD 1,498 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.08
-42.18%
6.05
Footer loading






